Navigation Links
ACGT Surpasses $25 Million Funding Milestone with Two New Grants
Date:3/16/2015

Stamford, CT (PRWEB) March 16, 2015

Alliance for Cancer Gene Therapy (ACGT) — the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer — has achieved a major milestone, surpassing $25 million donated to innovative and breakthrough cancer research. ACGT was founded by Barbara Netter and her late husband, Edward, in 2001 with the goal of transforming cancer into a manageable, treatable disease.

Pushing the foundation across the $25 million threshold are a pair of three-year, $250,000 grants to two esteemed scientists: Meenakshi Hegde, MD, of Texas Children’s Cancer Center at Baylor College of Medicine in Houston, TX, and Christopher Jewell, PhD, at University of Maryland, College Park. Dr. Hegde’s work will focus on immunotherapy, specifically adoptive cellular therapy for melanoma. Dr. Jewell’s research is centered on harnessing intra-lymph node gene therapy to promote tumor immunity. The grantees will develop genetically-modified T cells and cancer vaccines with the potential to stop cancer in its tracks.

“Drs. Hegde and Jewell are two outstanding scientists in the vanguard of treating and defeating cancer,” said Barbara Netter, ACGT’s President. “Their work offers tremendous hope to those battling cancer, and also to their loved ones.”

ACGT grants are awarded to promising researchers whose work dovetails with the foundation’s mission: Leveraging cell and gene therapies to supplant the more harrowing cancer treatments like radiation, chemotherapy and surgery. ACGT’s $25 million in grants have funded watershed research and trials such as those that activate patients’ own immune systems to battle cancer cells. These trials have saved the lives of cancer patients otherwise believed to be beyond treatment.

The two most recent grants continue ACGT’s mission of equipping innovative scientists with the tools and support to revolutionize the fight against cancer. ACGT grants range from $250,000 to $1 million, and reward both young, promising researchers and their more established colleagues. Past recipients include such pre-eminent scientists as University of Pennsylvania’s Dr. Carl June and Memorial Sloan-Kettering’s Dr. Michel Sadelain; this past summer, the Food and Drug Administration (FDA) granted “breakthrough” status to immunotherapy treatments for leukemia developed by each of these scientists for which ACGT provided early funding.

About Alliance for Cancer Gene Therapy (ACGT)
Established in 2001, ACGT (http://www.acgtfoundation.org) is the nation’s only not-for-profit dedicated exclusively to cell and gene therapy treatments for all types of cancer. One-hundred percent of contributions go directly to research. ACGT has funded 46 grants in the U.S. and Canada since its founding in 2001 by Barbara Netter, President, and her late husband, Edward, to conduct and accelerate critically needed innovative research. Since its inception, ACGT has awarded 31 grants to Young Investigators and 15 grants to Clinical Investigators, totaling more than $25 million in funding. ACGT is located at 96 Cummings Point Road, Stamford, CT 06902.

ACGT on Facebook: http://www.facebook.com/ACGTfoundation
ACGT on Twitter: http://www.twitter.com/ACGTfoundation
ACGT on YouTube: http://www.youtube.com/user/ACGTfoundation

Read the full story at http://www.prweb.com/releases/2015/03/prweb12585806.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. French Man Surpasses Two Years of Support with SynCardia Total Artificial Heart
2. SynCardia Total Artificial Heart Surpasses 100th Implant of 2013
3. YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group
4. Magnetic Resonance Imaging Systems Market Is Expected to Reach $6,802.7 Million by 2020 - New Report by MarketsandMarkets
5. The North America Polycarbonate Market (2013–2019) is Estimated to Reach $2474.0 Million by 2019 - A Report by MicroMarket Monitor
6. New Patient Safety Study Reveals Misdiagnosis of 1 in Every 200 Prostate Biopsy Patients, Wasting Over $880 Million in Unnecessary Healthcare Expenditures Annually
7. The Middle East & Africa IR Detector Market is Estimated to Reach $23.9 Million by 2019 – A Report by MicroMarket Monitor
8. One Million Solutions in Health™ Announces its Launch as a Non-Profit Geared towards Life Sciences and Healthcare Scientific Advances – and Sharing Solutions Worldwide
9. The Europe Phosphatic Fertilizer Market is Estimated to Reach $5,654.27 Million by 2019 – A Report by MicroMarket Monitor
10. BIOREM announces orders for $3.7 million.
11. Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... SOMERSET, N.J. (PRWEB) , ... ... ... today announced a long-term strategic agreement for the development and manufacturing of ... (SMA). , Through this collaboration, AveXis, a Novartis company, will have dedicated ...
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent stem cell ... eight military Veterans under the R3 Heroes Program. The Veterans included individuals and families ... Program allow anyone to nominate a military Veteran, teacher or first responder to receive ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named a ... the 2019 Innovative Product of the Year which highlights cutting-edge advancements and achievements ... Sensors Expo & Conference 2019, held this week in San Jose, California. ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from preclinical ... Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical ... change in crystallite size , Over 142% increase in particle size , ...
Breaking Biology Technology:
(Date:6/1/2019)... Md. (PRWEB) , ... May 31, 2019 , ... ... firm Wilson Sonsini Goodrich & Rosati recently invested in BioFactura’s $6M Series B ... BioFactura is now securing value-added institutional investors who bring significant financial and business ...
(Date:5/31/2019)... Calif. (PRWEB) , ... May 30, 2019 , ... ... clinical genetics testing company, and Mayo Clinic, have documented significant differences in the ... among racial and ethnic populations compared to non-Hispanic White women. Results will be ...
(Date:5/31/2019)... ... ... Enso Discoveries Chief Executive Officer, Patrick Farley, is honored to give back to ... his gratitude and respect for those who have served their country. In honor of ... presented a check for $1,000 to the Green Beret Foundation, via former US Army ...
Breaking Biology News(10 mins):